The Muscle Mag
“A lot of people don’t realize that stripping out everything else from a compound results in losing stability,” stated Balcombe. “Compounds rely on each other for stability, and when they are broken down, they may lose their bioactivity. Therefore, we aim to preserve the entire plant matrix while enhancing key components to enhance the plant’s performance in a unique way, validated through human clinical trials.”
Balcombe claims that Specnova is a decade ahead of other companies in the industry, citing examples such as vitamin C.
“We are able to load vitamin C at a high percentage in the liposome, no less than 70%. Our liposomal formulation significantly improves the stability of vitamin C, allowing over 30% more of the dose to enter the bloodstream,” he mentioned. “Vitamin C remains stable in the low pH of the stomach but becomes unstable in the higher pH of the small intestine, leading to a loss in a high pH environment.”
However, Balcombe and his team observed a noticeable increase in the amount of vitamin C retained in the small intestine due to their liposomal formulation.
“There were elevated levels in the blood for an extended period, exceeding 24 hours. Notably, we measured vitamin C levels in white blood cells and found a 20% increase in concentration compared to non-liposomal vitamin C for bioavailability,” he added.
Watch the interview to explore more about Specnova’s breakthroughs, including insights from clinical trials.
